miltefosine has been researched along with Malignant Melanoma in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teymouri, M | 1 |
| Farzaneh, H | 1 |
| Badiee, A | 1 |
| Golmohammadzadeh, S | 1 |
| Sadri, K | 1 |
| Jaafari, MR | 1 |
| Ragnarsson-Olding, B | 1 |
| Djureen-Mårtensson, E | 1 |
| Månsson-Brahme, E | 1 |
| Hansson, J | 1 |
2 other studies available for miltefosine and Malignant Melanoma
| Article | Year |
|---|---|
Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Delivery Syst | 2015 |
Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex).
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Melanoma; Neo | 2005 |